ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
308 |
125K |
106 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
308
|
125K
|
106
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
673 |
301K |
50 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
673
|
301K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
673 |
301K |
34 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
673
|
301K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
673 |
301K |
53 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
673
|
301K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
673 |
301K |
97 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
673
|
301K
|
97
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
308 |
125K |
57 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
308
|
125K
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
308 |
125K |
67 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
308
|
125K
|
67
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
308 |
125K |
117 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
308
|
125K
|
117
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
67 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.2M
|
67
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
112 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
10K
|
3.2M
|
112
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
71 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.2M
|
71
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
108 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
10K
|
3.2M
|
108
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
otherperspective
|
181 |
78K |
62 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
78K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
17K |
6.8M |
55 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
17K
|
6.8M
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
431K |
126 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
431K
|
126
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
431K |
75 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
431K
|
75
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
otherperspective
|
609 |
112K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
609
|
112K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
otherperspective
|
244 |
91K |
55 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
91K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
otherperspective
|
244 |
91K |
98 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
244
|
91K
|
98
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Outstanding 98.6% Success Rate in Striate Implant Study
|
|
otherperspective
|
32 |
11K |
39 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
32
|
11K
|
39
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
otherperspective
|
587 |
196K |
31 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
587
|
196K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.2K |
388K |
74 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.2K
|
388K
|
74
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.2K |
388K |
109 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.2K
|
388K
|
109
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.2K |
388K |
99 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
1.2K
|
388K
|
99
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.2K |
388K |
54 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.2K
|
388K
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.2K |
388K |
64 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.2K
|
388K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
otherperspective
|
943 |
403K |
112 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
943
|
403K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
17K |
6.8M |
53 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
17K
|
6.8M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
otherperspective
|
272 |
105K |
48 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
272
|
105K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
431K |
61 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
431K
|
61
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
431K |
94 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
431K
|
94
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
otherperspective
|
154 |
50K |
49 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
50K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
184K |
64 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
184K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
184K |
73 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
184K
|
73
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
184K |
84 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
184K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
otherperspective
|
78 |
26K |
77 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
26K
|
77
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
82 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
10K
|
3.2M
|
82
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
63 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
10K
|
3.2M
|
63
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
10K |
3.2M |
59 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
10K
|
3.2M
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
otherperspective
|
513 |
133K |
49 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
513
|
133K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
otherperspective
|
513 |
133K |
70 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
513
|
133K
|
70
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
otherperspective
|
716 |
206K |
71 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
206K
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Files for FDA Designations in Congenital Heart Disease
|
|
otherperspective
|
68 |
23K |
92 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
68
|
23K
|
92
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
17K |
6.8M |
57 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
17K
|
6.8M
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Report to Shareholders
|
|
otherperspective
|
74 |
24K |
89 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
74
|
24K
|
89
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
otherperspective
|
574 |
200K |
23 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
200K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
otherperspective
|
574 |
200K |
104 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
200K
|
104
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
otherperspective
|
3.4K |
1.2M |
42 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
otherperspective
|
60 |
25K |
61 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
25K
|
61
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
otherperspective
|
907 |
289K |
70 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
907
|
289K
|
70
|
|